Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Fintel reports that on April 10, 2025, Mizuho initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a Neutral ...

Mizuho initiated coverage of Tandem Diabetes (TNDM) with a Neutral rating and $20 price target The firm’s neutral stance reflects both the ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $35.11, a high ...

Some stocks are lagging the market for good reasons -- because their businesses look shaky and their prospects uncertain.

Tandem Diabetes Care, Inc. TNDM shares soared 7.6% in the ... the company’s reported sales grew by a staggering 44%, while worldwide pump shipments increased by more than 25%.

The pumps themselves generate just over half ... Revenue Growth: Over the 3M period, Tandem Diabetes Care showcased positive performance, achieving a revenue growth rate of 43.62% as of 31 ...

The doctors say barriers continue to prevent access to AID, including costs. Such barriers exemplify “the implicit ...

Tandem Diabetes Care develops innovative insulin pumps. One of its best-known devices is the t:slim X2, whose claim to fame is its size. It's a discreet option that can still hold about as much ...

DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience ...